House Vote On Pelosi’s Drug Pricing Bill Set For Next Week, Though Legislation Is Likely To Die In Senate
But the vote would give House Democrats an election talking point and let them show that they can govern despite the impeachment proceedings. The legislation would allow HHS to negotiate lower prices for up to 250 drugs per year, with the lower prices applied to people with private insurance as well as Medicare.
The Associated Press:
Pelosi Sets Medicare Showdown On Drug Costs And New Benefits
The House will hold a showdown vote next week on Speaker Nancy Pelosi's bill empowering Medicare to negotiate drug prices, expanded Thursday to provide seniors with dental, vision and hearing benefits not currently covered. Leading Democratic committee chairmen said the Congressional Budget Office has indicated that Pelosi's bill would save the government $500 billion over 10 years, which they pledged to use for new Medicare benefits and other health care priorities such as the National Institutes of Health and the opioid crisis. (Alonso-Zaldivar, 12/5)
The Hill:
House To Vote Next Week On Sweeping Bill To Lower Drug Prices
“We are going to give Medicare the power to negotiate lower drug prices, and make those prices available to Americans with private insurance as well as Medicare beneficiaries,” Pelosi said in a statement along with Majority Leader Steny Hoyer (D-Md.) and three key committee chairmen, Reps. Frank Pallone Jr. (D-N.J.), Richard Neal (D-Mass.) and Bobby Scott (D-Va.). “American seniors and families shouldn’t have to pay more for their medicines than what Big Pharma charges in other countries for the same drugs.” (Sullivan, 12/5)
Politico:
House To Vote On Pelosi Drug Pricing Bill Next Week
Left unclear is whether there will be a complete score of the projected savings from the legislation prior to the vote. Pelosi's office has said leaders wanted a full score before bringing the bill to the floor. The Congressional Budget Office to date has evaluated only the part of the bill, which allows for direct government negotiation of some Medicare drug prices. “We have now received enough guidance from CBO to bring the Lower Drug Costs Now Act to the Floor and to reinvest its savings in one of the most transformation improvements to Medicare since its creation," Pelosi, Majority Leader Steny Hoyer and Reps. Frank Pallone (D-N.J.), Richard Neal (D-Mass.) and Bobby Scott (D-Va.) said in a statement. (Karlin-Smith, 12/5)
The Hill:
Progressive Leader Warns Members Could Vote No On Drug Price Bill As It Stands
The co-chairman of the Congressional Progressive Caucus warned Thursday that some progressive lawmakers might vote against Speaker Nancy Pelosi’s (D-Calif.) bill to lower drug prices unless changes are made. “We have told leadership that there could be people who vote against the bill so they should be ready for that if things aren't included,” Rep. Mark Pocan (D-Wis.) told reporters after a meeting of the Progressive Caucus on Thursday, adding that the group had not done a formal vote count. (Sullivan, 12/5)
